ST

Sandhya Tiwari

Active Director Director DIN 09111602
DIN 09111602 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sandhya Tiwari

Data last updated:

Sandhya Tiwari is a Director at Xenomedix Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Xenomedix Pharmaceuticals Private Limited reported revenue of ₹19.2 Lakh (FY 2025).

DIN 09111602
Primary Designation Director
Industry Chemicals
First Appointment 26 Mar 2021
Oldest Company Age 5 yrs
Largest company Xenomedix Pharmaceuticals Private Limited · ₹19.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Mar 20212021₹19.2 Lakh (FY 2025)Active

Board colleagues of Sandhya Tiwari

NameDINCompanyDesignation
Sushil Tiwari09111536Xenomedix Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Xenomedix Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sandhya Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandhya Tiwari

Sandhya Tiwari currently holds 1 directorship: Xenomedix Pharmaceuticals Private Limited (Director, since 26 Mar 2021, revenue ₹19.2 Lakh (FY 2025)).

Sandhya Tiwari was first appointed on 26 Mar 2021 as Director at Xenomedix Pharmaceuticals Private Limited.

The current boards of Sandhya Tiwari's companies include Sushil Tiwari (Xenomedix Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available